© 2021 - Negotiamini. All Rights Reserved.
Editor’s note: This article, distributed by The Associated Press, was originally published on The Conversation website . The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.
By Sebnem Kalemli-Ozcan, University of Maryland
Rolling out a vaccine to stop the spread of a global pandemic doesn’t come cheap. Billions of dollars have been spent developing drugs and putting in place a program to get those drugs into people’s arms.
But amid an uneven distribution of vaccines – with poorer countries lagging far behind richer nations – another concern presents itself: the cost of not vaccinating everyone.
My colleagues and I sought to find out what the total hit to the global economy of uneven vaccination distribution might be.
To do so, we analyzed 35 industries – such as services and manufacturing – in 65 countries and examined how they were all linked economically in 2019, before the pandemic. For example, the construction sector in the U.S. relies on steel imported from Brazil, American auto manufacturers need glass and tires that […]